about
Traws Pharma Inc is a clinical-stage biopharmaceutical company dedicated to developing novel therapies to target critical threats to human health in respiratory viral diseases. It is advancing novel investigational antiviral agents that have potent a...
Read More
1.56
-0.16
(-9.30%)
597.2K
XNAS Volume
High vol. this week
XNAS 14 May, 2026 12:15 PM (EDT)
Board Meeting
The next board meeting for Traws Pharma Inc is on 15 May 2026 for the purpose of Traws Pharma Inc First Quarter Earnings Results for 2026
See details
Not Eligible
Mid Valuation
Technically Neutral
Traws Pharma Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..